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Female human pluripotent stem cells show vast het-
erogeneity regarding the status of X chromosome
inactivation. By comparing the gene expression pro-
file of cells with two active X chromosomes (XaXa
cells) to that of cells with only one active X chromo-
some (XaXi cells), a set of autosomal genes was
shown to be overexpressed in the XaXa cells. Among
these genes, we found significant enrichment for
genes regulated by the X-linked transcription factor
ELK-1. Comparison of the phenotype of XaXa and
XaXi cells demonstrated differences in programmed
cell death and differentiation, implying some growth
disadvantage of the XaXa cells. Interestingly, ELK-
1-overexpressing cells mimicked the phenotype of
XaXa cells, whereas knockdown of ELK-1 with small
hairpin RNA mimicked the phenotype of XaXi cells.
When cultured at low oxygen levels, these cellular
differences were considerably weakened. Our anal-
ysis implies a role of ELK-1 in the differences
between pluripotent stem cells with distinct X chro-
mosome inactivation statuses.
INTRODUCTION
X chromosome inactivation (XCI) is the mechanism by which
dosage compensation of the sex chromosome is achieved in
mammals (Leeb andWutz, 2010; Lyon, 1962). It has been shown
that inmouse embryonic stem cells (mESCs) andmouse induced
pluripotent stem cells (miPSCs) both X chromosomes are active,
and inactivation occurs during differentiation in a random fashion
(Maherali et al., 2007; Navarro et al., 2008). However, the status
of XCI in human embryonic stem cells (hESCs) and human
induced pluripotent stem cells (hiPSCs) is much more complex,
where different human pluripotent stem cell (hPSC) lines show
either two active X chromosomes (XaXa cells) or one active
and one inactive X chromosome (XaXi cells) (Bruck and Benve-
nisty, 2011; Dvash et al., 2010; Mekhoubad et al., 2012; Silva
et al., 2008; Tchieu et al., 2010; Tomoda et al., 2012). This vari-
ability can be seen in long-term culture of hPSCs, and also after262 Cell Reports 4, 262–270, July 25, 2013 ª2013 The Authorsreprogramming. The basis for this variability is widely investi-
gated, and includes, among others, medium conditions (Hanna
et al., 2010), oxygen levels, (Lengner et al., 2010), and type of
feeder cells (Tomoda et al., 2012).
However, the impact of this epigenetic variability on the
phenotype of these cells is yet unclear. In this study, we compare
XaXa and XaXi female hPSCs and show molecular and cellular
phenotypic differences between the two cell types. We suggest
that the X-linked transcription factor, ELK-1, regulates some of
these differences and affects the culture growth properties of
the XaXa hPSCs. We also show that culture conditions such
as oxygen levels reduce these differences and diminished the
culture disadvantage of the XaXa cells. The potential impact of
these phenotypic differences on early development research,
as well as on clinical use of these cells, emphasizes the impor-
tance of studying this epigenetic variability.
RESULTS
Comparison of the Transcriptome of XaXa and XaXi
Female Human Pluripotent Stem Cell Lines
In order to identify the impact of X chromosome status on the
molecular phenotype of hPSCs, we compared the gene expres-
sion profile of cell lines with either one or two active X chromo-
somes. To establish X inactivation status, we used microarray
data from 24 female PSC lines and analyzed the expression of
the entire set of genes on their X chromosome (Bruck and Ben-
venisty, 2011). Ten cell lines were identified as XaXa cells, and 14
cell lines were identified as cells XaXi cell lines (Figures 1A, S1A,
and S1B; Table S1). As described by us and others (Bruck and
Benvenisty, 2011; Nazor et al., 2012), there was another group
of partially active cell lines that showed inactivation in a regional
fashion. However, we have decided not to use these cell clones
in the current work. By comparing the expression of autosomal
genes between XaXa and XaXi cells, using the Expander pro-
gram (Ulitsky et al., 2010), more than 3,000 genes were upregu-
lated (p < 0.05) in the XaXa cells compared to the XaXi cell lines
(Figure 1B). We then searched for transcription factors that may
regulate these autosomal genes, by analysis of common regula-
tory elements in their promoters. Using the PRIMA analysis tool
(Ulitsky et al., 2010), we found that the transcription factor that
most significantly binds to these genes (p value = 5.1E-13) is
the X-linked transcription factor ELK-1 (Figure 1C). ELK-1
resides on Xp11.23, within the region that is silenced during
X inactivation, suggesting its expression levels would vary ac-
cording to the status of XCI (Figure 1D). Furthermore, binding
sites of ELK-1 were found very near the transcription start site
in a majority of the overexpressed genes (Figure 1E). ELK-1 is
part of the E-twenty six transcription factors implicated in cell
proliferation (Sharrocks, 2002), response to cellular stress (Boros
et al., 2009), and apoptosis (Barrett et al., 2006; Shao et al.,
1998). Thus, our results show that there are molecular differ-
ences between XaXa and XaXi cell lines, and that these differ-
ences may be partly controlled by the levels of the ELK-1
transcription factor, expressed from the X chromosome.
Cellular Phenotype Differences between XaXa and XaXi
Cells
Female human pluripotent cells with two active X chromosomes
occur infrequently and often becomes inactive (Bruck and Ben-
venisty, 2011; Fan and Tran, 2011; Amps et al., 2011; Silva et al.,
2008; Tchieu et al., 2010). We have thus hypothesized that XaXa
cells may have some growth disadvantage compared to the
XaXi cells. To study the cellular phenotype of XaXa and XaXi
hPSCs, we have characterized three cell lines from each group.
This characterization included analysis of the expression pattern
of heterozygous SNPs along the X chromosome (Figure 1F),
identification of the inactive X by immunostaining for trimethyla-
tion of histone H3 on lysine 27 (H3K27me3) (Figure 1G, I–IV), and
demonstration of more than 10-fold higher expression of XIST
RNA transcript in XaXi cells compared to XaXi cells. In addition,
karyotype analysis of the cells ensured their diploid status (Fig-
ure S1C). In order to compare the cell growth of the XaXa to
the XaXi cell lines, two parameters were analyzed: apoptosis
levels and the tendency of the cells to spontaneous differentia-
tion. In order to identify whether there are differences in the levels
of apoptosis between the two cell types, we stained the cells with
propidium iodide (PI) and an annexin V-fluorescein isothiocya-
nate (FITC) and analyzed them by fluorescence activated cell
sorting (FACS) (Rieger et al., 2011). XaXa cells showed signifi-
cantly higher levels of apoptosis compared to the XaXi cells
(11.4% ± 1.27% versus 5.6% ± 0.4%, respectively, p = 0.023,
Figure 2A, I, II, and IV). We next examined whether XCI status
affects the ability of the cells to stay undifferentiated; TRA-
1–60 staining (a marker of undifferentiated cells) showed that
XaXa cells differentiated more readily than XaXi cells, with
around 2-fold higher levels of differentiated cells in the XaXa
cell population. (Figure 2B, I, II, and IV). The differences in the
pluripotent state between XaXa and XaXi cells have also been
shown by the different expression levels of the pluripotent
markers NANOG andOCT4 (Figures S2A and S2B, respectively).
These results suggest that differences in XCI statemay affect the
cellular phenotype of the cells at the levels of programmed cell
death and differentiation. In addition, the high rates of apoptosis
and differentiation in the XaXa cells imply for some growth disad-
vantage of these cells in culture.
Overexpression of the X-Linked Transcription Factor
ELK-1 Mimics the Phenotype of XaXa Cells
To examine the involvement of ELK-1 in the cellular differences
between XaXa and XaXi cell lines, we have genetically manipu-lated its expression in hESCs. Thus, we overexpressed ELK-1
in one of the XaXi cell lines. Two clones in which ELK-1 is over-
expressed were further characterized (C7 and C17, Figures 2C
and 2D).
The contribution of ELK-1 to the cellular phenotype was deter-
mined by comparison of the ELK-1-overexpressing cells to both
XaXa cells and XaXi cells. Examination of apoptosis revealed a
significant increase in the percentage of apoptotic cells in ELK-
1-overexpressing cells compared to XaXi cells, as determined
by annexin-V/PI staining (14.1% ± 1.1%, Figure 2A, III). More-
over, these high levels of apoptosis resemble the levels of
apoptosis in the population of the XaXa cells (Figure 2A, IV),
and, as such, ELK-1-overexpressing cells mimicked the pheno-
type of the XaXa cells. We also examined whether ELK-1
expression affects the ability of the cells to stay undifferentiated;
TRA-1–60 staining showed that cells overexpressing ELK-1
differentiated more readily than XaXi cells (Figure 2B, III). More-
over, this relative inability of these cells to stay undifferentiated
resembles that of XaXa cells Figure 2B, IV). The pluripotent state
of ELK-1-overexpressing cells has also been shown by the
different expression levels of the pluripotent markers NANOG
and OCT4 (Figures S2A and S2B, respectively). The higher rates
of apoptosis along with the enhanced tendency to spontane-
ously differentiate imply for a growth disadvantage of the ELK-
1-overexpressing cells compared to the XaXi cells, the same
disadvantage as identified for the XaXa cells. We can conclude
that high expression levels of ELK-1, whether caused by the
expression from two active X chromosomes, or from the ELK-1
transgene, results in an unfavorable phenotype compared to
inactive cells with lower levels of ELK-1 expression.
Downregulation the ELK-1 Gene Mimics the Phenotype
of XaXi Cells
In order to determine the functional significance of ELK-1 in the
unfavorable phenotype of XaXa cells, we have downregulated
the expression of ELK-1 in XaXa cells using two types of small
hairpin RNA (shRNA) molecules (Figure 3A; Experimental Proce-
dures). Comparison of the levels of apoptosis between cells
expressing ELK-1 shRNA and native XaXa cells revealed a signif-
icant reduction in the levels of apoptosis in cells expressing the
ELK-1 inhibitors (Figure 3B). In addition, these cells also showed
lower percentages of differentiated cells compared to XaXa cells
(Figure 3C), and higher expression of the pluripotent genes
NANOG and OCT4 (Figures S2A and S2B). Thus, by downregu-
lating the expression levels of ELK-1 in XaXa cells, we could
affect the phenotypes they showed in culture including high
levels of apoptosis and differentiation.
XaXaCells DisplayGrowthDisadvantage at HighOxygen
Levels, but Not at Low Oxygen Levels
Numerous studies reported protective effects of low oxygen
concentrations (5%) compared to high oxygen levels (20%)
(Bode and Dong, 2007; Greer Card et al., 2010; Xu and Davis,
2010) for hESC growth. Specifically, it was reported that deriva-
tion and culture of female hESCs at low oxygen prevents XCI and
keeps the persistence of two active X chromosomes (Lengner
et al., 2010). In order to determine the involvement of oxygen
exposure in the phenotypic differences, we evaluated the levelsCell Reports 4, 262–270, July 25, 2013 ª2013 The Authors 263
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Figure 1. Molecular Differences between XaXa and XaXi Cell Lines
(A) Moving average plot of expression analysis of genes on the X chromosome. Shown are relative gene expression levels along the X chromosome. Average
of ten XaXa cell lines or 14 XaXi cell lines are shown in red. The blue line represents the relative expression of genes on X chromosome in male pluripotent
stem cells.
(B) Expression heatmap of genes upregulated (red) in the XaXa cell lines compared to the XaXi cell lines.
(C) Enrichment of ELK-1 binding site. Shown are the p values of the enrichment for the numbers of genes predicted to be regulated by each transcription factor.
(legend continued on next page)
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of apoptosis and differentiation in ELK-1-overexpressing cells,
XaXa cells and XaXi cells, when cultured under low oxygen con-
ditions (5%). Examination of cellular apoptosis revealed very low
percentages of apoptotic cells (<5%) in all three cell types, with
no significant differences (Figure 3D), resembling the levels of
apoptosis in XaXi cells under high oxygen levels (Figure 2A).
Tra-1-60 staining revealed no significant differences between
ELK-1-overexpressing cells, XaXa cells and XaXi cells (Fig-
ure 3E). Our data suggest that the growth disadvantage of the
XaXa cells exists mainly at high oxygen levels but not at low
oxygen levels. Examination of ELK-1 expression in different
oxygen levels revealed similar transcription of the gene (Fig-
ure S2C), suggesting that oxygen levels affect genes down-
stream of ELK-1.
In order to further analyze the effects of oxygen levels on XCI in
hiPSCs, we generated a female iPSC line from human fibroblasts
(iPS-GM26, see Experimental Procedures). This cell line ex-
presses pluripotency markers such as alkaline phosphatase
(Figure S3A), OCT4 (Figures S3B and S3F), Tra-1-60 (Fig-
ure S3C), NANOG (Figure S3D), and LIN28 (Figure S3E), differen-
tiates in vivo into teratomas containing all three embryonic germ
layers (Figure S3G), and displays a normal karyotype (Fig-
ure S3H). We then analyzed the status of X chromosomes in an
early passage clone of these cells by determining XIST expres-
sion levels (Figure 4A), expression of X-linked polymorphic sites
(Figure 4B), and immunostaining for the inactive X chromosome
marker, H3K27me3 (Figure 4C). This analysis revealed a mixed
population of XaXa and XaXi cells (Figure 4D). We then deter-
mined whether the XaXi cells show growth advantage, and
whether oxygen levels affect this phenotype. For this purpose,
we divided the hiPSCs into two cultures and grew them between
6 and 16 passages in either high or low oxygen levels (Figure 4D).
When growing at high oxygen levels, the cell population
becomes homogenous and comprises inactive cells only (98%
of the colonies are inactive, Figure 4C), which reinforces the
notion of growth disadvantage of the XaXa cells. However,
when growing at low oxygen levels, the cell population remained
heterogeneous and showed 51% ± 2% of active colonies (Fig-
ure 4C). The same results were seen when we analyzed a mixed
population of the hESC line CSES35 (Figures S3I and S3J).
DISCUSSION
Here, we demonstrate differences in the molecular and cellular
phenotypes between XaXa and XaXi hPCS lines. The analysis
of the differences in the transcriptome revealed molecular differ-
ences between the two cell types and enables us to identify the
X-linked transcription factor ELK-1 as a regulator gene. At the(D) Locations of the ELK-1 binding sites with respect to the transcriptional start sit
bin sizes of 200 bp for quantification.
(E) ELK-1 location on X chromosome.
(F) Heterogeneous SNPs along the X chromosome. The XaXa cells show biallelic
shown for the XaXi cells.
(G) Immunostaining for H3K27me3 shows cells with inactive X chromosome in th
XaXa cells (represented by the CSES2 cell line). Scale bars represent 50 mm.
(H) XIST expression levels. Box plot showing expression levels of XIST (the lowe
XaXa cells show lower levels of XIST than XaXi cells.
See also Figures S1 and S2.cellular level, XaXa cells showmore apoptosis and differentiation
than XaXi cells, implying for some growth disadvantage of these
cells. These findings and the findings of Anguera et al. (2012)
suggest that female hPSCs change their molecular and cellular
phenotypes twice: once during X chromosome inactivation,
and then when Xist ceases to be expressed.
ELK-1-overexpressing cells mimic the phenotype of XaXa
cells and show higher percentages of apoptosis and differentia-
tion compared to XaXi cells. In addition, cells expressing ELK-1
shRNA show low levels of apoptosis and differentiation similar to
the phenotype of XaXi cells. Of the genes regulated by ELK-1,
several are involved in processes such as cell proliferation,
differentiation, and programmed cell death, e.g., MAPK9 and
RAD9a (Bode and Dong, 2007; Greer Card et al., 2010; Sabapa-
thy andWagner, 2004; Xu and Davis, 2010). Real-time PCR anal-
ysis confirmed the expression pattern of these genes in male
PSCs, XaXa cells, XaXi cells, and ELK-1-overexpressing cells
(Figures S1D and S1E).
Surprisingly, the cellular differences between XaXa and XaXi
cells were reduced when cells grew at low oxygen conditions.
Additionally, we have analyzed a mixed population of XaXa
and XaXi hiPSCs. When we analyzed the status of the X chromo-
somes in passage 5, we identified a mixed population of XaXa
and XaXi hiPSCs implying for reactivation of X chromosome dur-
ing the reprogramming process. After several passages of these
cells at high oxygen levels, we completely lost the XaXa cells
population, suggesting growth disadvantage of the XaXa cells.
Another line with mixed population of XaXa and XaXi hESCs
was analyzed and revealed the same results. These findings
may explain the numerous reports about hPSCs showing inac-
tive X chromosome (Bruck and Benvenisty, 2011; Dvash et al.,
2010; Mekhoubad et al., 2012; Silva et al., 2008; Tchieu et al.,
2010), because these cells were grown at high oxygen levels,
XaXi cells took over the culture. Intriguingly, our findings show
that the XaXi hiPSCs inactivate the same X chromosome that
was inactive in the parental fibroblast cells (Figure 4B). Analyzing
hiPSCs after several passages at high oxygen levels might reveal
a population of XaXi cells showing the same inactive X as the
parental fibroblasts, as a result of an epigenetic memory of the
modifications following XIST expression on the inactive X chro-
mosome. Alternatively, growing this mixed population at low
oxygen levels enabled the survival of the XaXa cells in culture.
These findings are consistent with the results of Lengner et al.
(2010), where hPSC with two active X chromosomes were
derived under low oxygen conditions. It seems that the low oxy-
gen enabled the growth of the XaXa cells. Similar to our observa-
tion, when Lengner et al. (2010) exposed the cells to atmospheric
oxygen, the cells underwent irreversible XCI.e (TSS). The distances corresponding to each of the regions were grouped into
expression of these SNPs, whereas monoallelic expression of these SNPs was
e population of XaXi cells (representative picture of CSES7 cells), but not in the
r and upper quartiles correspond to the 10th and 90th percentile, respectively).
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Figure 2. ELK-1-Overexpressing Cells Mimic the Phenotype of the Active Cell Line
(A and B) Cellular phenotype determined by FACS analysis. (A) Analysis of apoptosis in XaXa (I), XaXi (II), and ELK-1-overexpressing cells (III). XaXi cells show
lower percentage of apoptotic cells compared to XaXa cells and ELK-1-overexpressing cells (IV). (B) Analysis of differentiation in XaXi (I), XaXa (II), and ELK-1-
overexpressing cells (IV). Cells were stained with antibody against Tra-1-60. Green dots represent the positive cells. All cells are FITC negative. XaXa cells and
ELK-1-overexpressing cells tend to differentiate more readily than XaXi cells. (IV).
(C) A scheme of a vector expressing ELK-1 gene under the CMV promoter.
(D) Real-time PCR analysis of the expression levels of ELK-1 in XaXa cells, XaXi cells, fibroblasts, male PSC, and two ELK-1-overexpressing clones.
Error bars represent SEs. *p% 0.05, **p% 0.01. See also Figure S2.Our analysis revealed genes that are upregulated in either
XaXa cells or ELK-1-overexpressing cells compared to XaXi
cells. In this population of genes, we found a highly signifi-
cant enrichment for mitochondrion genes (the XaXa cells
show enrichment score of 24.73, and corrected p value of
1.53E-42 for the mitochondrion genes according to DAVID
functional annotation analysis) (Huang et al., 2007). This
finding raises the possibility that the phenotypic differences
between the cells, which exist only at high oxygen levels,
might be related to mitochondrial activity. Further analysis is
needed in order to analyze the crosstalk between ELK-1
and cell metabolism.
In this study, we demonstrate an epigenetic variance between
female hPSCs and suggest a phenotypic outcome of this differ-
ence. Understanding this phenotypic diversity is important for
the use of female hPSCs for disease modeling and for clinical
studies. In addition, our findingsmay shed light on early develop-266 Cell Reports 4, 262–270, July 25, 2013 ª2013 The Authorsmental events in human embryogenesis and are relevant for
in vitro culturing of hPSCs.
EXPERIMENTAL PROCEDURES
Gene Expression Database and Moving Average Plot Analysis
Gene expression profiles were obtained as described previously (Bruck and
Benvenisty, 2011). Table S1 includes all the cell lines that were included in
the analysis. Moving-average plot of X chromosome was performed as
described previously (Bruck and Benvenisty, 2011).
DNA Microarray Analyses
Total RNA was extracted according to the manufacturer’s protocol (5 PRIME).
Global gene expression analysis was performed using the U133 plus 2.0
microarray platform (Affymetrix) according to the manufacturer’s protocol.
Arrays were normalized using MAS5 probe set condensation algorithm in
the Affymetrix Expression Console. Heatmap was performed with Partek
Genomics Suite version 6.3 (http://www.partek.com). Further analysis was
made using the Expander software (http://acgt.cs.tau.ac.il/expander/). For
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promoter analysis, we used PRIMA software (http://acgt.cs.tau.ac.il/prima/
PRIMA.htm) and the Allegro software (http://acgt.cs.tau.ac.il/allegro/).
In order to identify genes that are regulated by the ELK-1 transcription
factor, and control the cellular phenotype, we used a list of genes that were
significantly upregulated (p value < 0.05) in both the XaXa cells and in the
ELK-1-overexpressing cells in comparison to the inactive cells. From these
genes, we have created a list of genes with fold change between ELK-1-over-
expressing cells and inactive cells that was higher than 1.2. In addition, the
expression levels of these genes in the ELK-1-overexpressing clones was
higher than 300, and they contained ELK-1 binding site according to Amadeus
software (http://acgt.cs.tau.ac.il/amadeus/). This list of genes was then sorted
according to the fold change and p value of each gene in addition to prefera-
bility to genes related to apoptosis, cell cycle, or differentiation according to
DAVID.
Cell Culture
hESC lines CSES2, CSES7, CSES25, CSES35, and CSES50 were cultured
on mouse embryonic fibroblasts (MEFs) and grown as previously described
(Dvash et al., 2010). All experiments were done between passages 6 and
24. Female primary fibroblasts of cell line GM02226 were purchased
from the Coriell Institute and cultured in MEM (Sigma-Aldrich, M5650)
supplemented with 15% fetal calf serum (FCS) (Biological Industries),
2 mM L-glutamine (Biological Industries), 50 units ml1 penicillin, and
50 mg ml1 streptomycin (Biological Industries). hESC and hiPSC cultures
were grown in hESC medium containing Knockout Dulbecco’s Modified
Eagle’s Medium (Gibco) supplemented with 15% Knockout Serum Replace-
ment (Gibco), 2 mM L-glutamine (Biological Industries), 0.1 mM nonessential
amino acids (Biological Industries), 0.1 mM b-mercaptoethanol (Sigma-
Aldrich), and 4–8 ng ml1 basic Fibroblast Growth Factor (bFGF) (Cytolab).
All cells were maintained in a humidified incubator at 37C and 5% CO2.
For low oxygen experiments oxygen level at the incubator was set to 5%
oxygen.
Introduction of ELK-1 into an XaXi Cell Line
The ELK-1 complementary DNA (cDNA) sequence was amplified using PCR
(see Table S2 for a full primers list). The PCR product was then inserted into
the pGEM vector (Promega) and fused to the N1-EGFP construct. TransIT-
LT1 (Mirus) transfection reagent was used to transfect CSES7 cells with the
ELK-1 vector. After transfection, cells were treated with 100 mg/ml of G418.
Colonies resistant to the antibiotic were manually expanded.
Downregulation of Elk-1 Using Small Hairpin RNA
XaXa hESCs (CSES2) were electroporated with different shRNA molecules to
silence ELK-1 (TRCN 0000007451-MISSION shRNA, Sigma-Aldrich). Thus,
cells were exposed to double 320 V, 200 mF pulse at room temperature using
the Bio-Rad Gene Pulser Xcell (0.4 cm gap cuvette; Bio-Rad), incubated for
10 min at room temperature and plated at high density on one 10 cm culture
dish containing MEFs. hESC clones contain sh-ELK-1 were selected using
puromycin.
Fluorescence-Activated Cell Sorting Analysis
For differentiation analysis, cells were dissociated using Tripleselect (Gibco),
washedwith fluorescence-activated cell sorting (FACS)medium (PBS contain-
ing 10%FCS), incubate with Tra-1-60 antibody for a half hour (BDPharmingen,Figure 3. Affecting the XaXa Cell Phenotype by the Downregulation of
(A) Real-time PCR analysis of the expression levels of ELK-1. XaXa cells show s
expressing ELK-1 shRNA and XaXi cells.
(B) Analysis of apoptosis levels in XaXa cells compared to two clones of cells expr
percentage of apoptotic cells compared to XaXa cells.
(C) Analysis of differentiation in XaXa compared to two clones of cells expressing
represent the positive cells. All cells are FITC negative. XaXa cells tend to differe
(D and E) Shown are analyses of the levels of apoptosis and differentiation in Xa
oxygen conditions (5%). (D) Low percentages of apoptosis (<5%) were determin
levels of differentiation between XaXi cells, XaXa cells, and ELK-1-overexpressin
Error bars represent SEs. *p% 0.05, **p% 0.01. See also Figure S2.
268 Cell Reports 4, 262–270, July 25, 2013 ª2013 The Authors1:40), and washed with FACS medium again. Cell-cycle analysis was per-
formed using PI staining; cells were trypsinized and suspended in PBS. Cold
methanol was added to the cells for at least 2 hr in 20C and then washed
and suspended with PBS containing 0.2 mg/ml RNase for a half hour. PI was
added to the cells to a final concentration of 50 mg/ml for 5 min. Annexin-V
staining for apoptosis detection was performed using an annexin-V kit (Bender
MedSystems) according to the manufacturer’s instructions. The FACS
analysis was performed using the FACSCalibur system or FACSaria system
(Becton Dickinson). The analysis was performed on CellQuest software (BD).
Forward and side-scatter plots were used to exclude dead cells and debris
from the histogram analysis.
Immunocytochemistry
For immunocytochemistry staining, cells were fixed with 4% (v/v) parafor-
maldehyde (BioLab) for 10 min at room temperature. After washing with
PBS, the cells were blocked for 15 min with PBS containing 5% (v/v) FCS
(Beit Haemek), 0.1% (v/v) Tween 20 (JT Baker), and 0.1% (v/v) Triton X-
100 (Sigma-Aldrich). Staining with primary antibodies was performed for
2 hr at room temperature with antibodies (diluted in wash buffer: PBS con-
taining 0.1% Tween 20 and 0.1% Triton X-100, as indicated) against OCT4
(1:200, Santa Cruz Biotechnology), TRA-1-60 (1:500, Santa Cruz), or
H3K27me3 (1:400, Millipore). Secondary antibodies used were cyanine-3
(Cy3)-conjugated rabbit anti-goat immunoglobulin (Ig) M, donkey anti-rabbit
IgG, or rabbit anti-mouse IgG (1:200, Jackson ImmunoResearch Labora-
tories) following staining with Hoechst 33342 (Invitrogen) to detect the cell’s
nucleus.
Genomic DNA and RNA Isolation and Reverse Transcription
Total genomic DNA was extracted using genomic DNA extraction kit (Real
Biotech Corporation), and RNA (DNase treated) was purified with Total RNA
Extraction kit (5 prime). One microgram of total RNA was used for reverse
transcription reaction using ImProm-II reverse transcriptase (Promega).
For sequencing and quantitative experiments, PCRs were performed with
ReadyMix (Sigma-Aldrich); for overexpression experiments, PCRs used
Herculase II Fusion DNA polymerase (Agilent Technologies). Quantitative
real-time PCR was performed with 1 mg of RNA reverse transcribed to cDNA
and TaqMan Universal MasterMix or SYBRGreen qPCRSupermix (see primer
list below; Applied Biosystems) and analyzed with the 7300 real-time PCR
system (Applied Biosystems). All samples were normalized to the levels of
GAPDH. A full description of primer sequences and annealing temperature
can be found in Table S2.
SNP Analysis
GenomicDNAorcDNAwasamplifiedwithPCR(seeprimerssequencesatTable
S2) and sent for sequencing. The results were analyzed using the PeakPicker2
software (http://genomequebec.mcgill.ca/publications/pastinen/).
Analysis of Gene Expression Profile of the ELK-1-Overexpressing
Cells
In order to reduce false-positive hits, we took into account only genes that
are upregulated in both the XaXa cells and in the ELK-1-overexpressing
cells in comparison to the XaXi cells. We gave each gene a score based on
its p value, fold change in expression levels, average expression levels,
and annotation according to DAVID functional annotation tool intoELK-1 or by Culturing the Cells in Low Oxygen Levels
ignificantly higher expression levels of ELK-1 compared to two clones of cells
essing ELK-1 shRNA. XaXi cells and cells expressing ELK-1 shRNA show lower
ELK-1 shRNA. Cells were stained with antibody against Tra-1-60. Green dots
ntiate more readily than XaXi cells and cells expressing ELK-1 shRNA.
Xi cells, XaXa cells, and ELK-1-overexpressing cells when culture under low
ed in all examined cells. (E) No significant differences were determined in the
g cells.
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Figure 4. Analysis of the Status of X Chromosome Inactivation in
Female hiPSCs Grown at Different Oxygen Levels
Shown from left to right are results for female fibroblasts, iPSCs at passage 5,
iPSCs grown at high oxygen levels, and iPSCs grown at low oxygen levels.
(A) Relative expression levels of XIST as determined by real-time PCR.
(B) Allelic ratios imply for the levels of the expression of the active allele.
Fibroblasts express only G and show no expression of the C allele. Expression
of the C allele implies reactivation of the inactive X chromosome.
(C) Percentages of colonies positive for the inactive X chromosome marker
H3K27me3.apoptosis, differentiation, and cell cycle. The genes with the highest score are
discussed.Production of Female Induced Pluripotent Stem Cells
For production of viral particles, 293T cells were transfected using Fugene 6
(Roche) with 4.5 mg of pMXs retroviral vectors containing human OCT4,
SOX2, KLF4, or c-MYC and 4.5 mg of PCL-Ampho plasmid. At 24 hr after
transfection, the culture was replacedwith freshmedium, and 48 hr after trans-
fection, the supernatant was collected, filtered through a 0.45-mMcellulose ac-
etate filter (Whatman), and supplemented with 4 mg ml1 of Polybrene (Sigma-
Aldrich). Fibroblast cells (600,000; Coriell, GM02226) were infected with viral
particles encoding the four factors. On day 4 after infection, the cells were
transferred to hESC growth conditions, supported by mitomycin-C-treated
mouse embryonic feeders. Morphological changes began to occur about
12 days after infection. Colonies with embryonic stem cell-like morphology
were manually expanded.Teratoma Formation
Female hiPSC line was grown to semiconfluence in a 10 cm tissue culture plate
and harvested by trypsin treatment. The cells were then injected under the
back leg of NOD-SCID mice (Jackson Laboratory). Six weeks after injection,
tumors were dissected and cryopreserved in O.C.T. compound (Sakura Fine-
tek). Several 1 mm slices were then cut and stained with hematoxylin and eosin
(Sigma). All experimental procedures were approved by the ethics committee
of the Hebrew University.Alkaline Phosphatase Staining
Alkaline phosphatase staining was performed according to the instructions of
the Leukocyte Alkaline Phosphatase kit (Sigma-Aldrich).ACCESSION NUMBERS
Microarray data for the ELK-1 overexpressing cells were deposited in theGene
Expression Omnibus and can be found under accession number GSE48792.SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures and two tables and can be
foundwith this article online at http://dx.doi.org/10.1016/j.celrep.2013.06.026.ACKNOWLEDGMENTS
The authors wish to thank all members of the lab for their technical support and
helpful discussions. In addition, we would like to thank Yonatan Stelzer and
Daniel Ronen and Nadav Sharon for critical reading of this manuscript. We
thank Tamar Golan-Lev for her assistance with the graphic design. N.B. is
the Herbert Cohn Chair in Cancer Research. This research was supported
by the Legacy Heritage Biomedical Science Partnership Program of the Israel
Science Foundation (grant 1252/12) and the Centers of Excellence Legacy
Heritage Biomedical Science Partnership (grant 1801/10).
Received: October 3, 2012
Revised: June 2, 2013
Accepted: June 24, 2013
Published: July 18, 2013(D) Schematic presentation of the data. Fibroblast cells are all inactive cells.
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whereas, when grown at low oxygen levels, the culture still contains active
cells.
Error bars represent SEs. *p% 0.05, **p% 0.01. See also Figure S3.
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